AJR Join ARRS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scialpi, M.
Right arrow Articles by Rotondo, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scialpi, M.
Right arrow Articles by Rotondo, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2000; 175:751-757
© American Roentgen Ray Society


Small Renal Masses

Assessment of Lesion Characterization and Vascularity on Dynamic Contrast-Enhanced MR Imaging with Fat Suppression

Michele Scialpi1, Arcangelo Di Maggio2, Massimi Midiri3, Angelo Loperfido2, Giuseppe Angelelli3 and Antonio Rotondo3

1 Department of Radiology, SS Annunziata Hospital, via Bruno, 74100 Taranto, Italy.
2 Department of Nephrology, SS. Annunziata Hospital, 74100 Taranto, Italy.
3 Department of Radiology, University Hospital, Piazza Giulio Cesare, 70124 Bari, Italy.

Received August 16, 1999; accepted after revision February 8, 2000.

 
Address correspondence to M. Scialpi, via Solito 83, 74100 Taranto, Italy (michelescialpi{at}libero.it ).


Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
OBJECTIVE. The aim of our study was to characterize renal lesions equal to or smaller than 3.0 cm using dynamic contrast-enhanced MR imaging with fat suppression by means of quantitative analysis of signal intensity.

MATERIALS AND METHODS. We retrospectively reviewed the MR imaging examinations of 35 patients (20 with renal cell carcinoma, eight with angiomyolipoma, and seven with complicated cysts) who were studied with spin-echo and dynamic fat-suppressed gradient-recalled echo MR sequences, before and after the administration of gadopentetate dimeglumine. Every 30 sec after contrast injection, we measured the lesion percentage of enhancement and the ratio of contrast (lesion—renal cortex signal intensity difference) to noise.

RESULTS. Ten renal cell carcinomas were classified as hypervascular (enhancement greater than that of renal cortex) and 10 as hypovascular. The percentage of enhancement of hypervascular carcinomas was similar to that of renal cortex until 150 sec and greater in the late sequences (180-210 sec, p < 0.01). Hypovascular carcinomas had a lower percentage of enhancement than hypervascular carcinomas (60-210 sec, p < 0.005). Angiomyolipomas, after an early enhancement peak, showed values similar to those of hypovascular carcinomas. Complicated cysts had very low enhancement (p < 0.001). The baseline contrast-to-noise ratio was negative for all lesions (hypointensity with respect to renal cortex). After gadolinium injection, the contrast-to-noise ratio of hypervascular carcinomas rose, becoming positive after 150 sec. Until 60 sec, the contrast-to-noise ratio of hypovascular carcinomas declined slightly, whereas that of angiomyolipomas and cysts fell sharply; then the three curves remained stable (60-210 sec, p < 0.05 for all matches except angiomyolipomas versus cysts).

CONCLUSION. Quantitative analysis of signal intensity variations during dynamic contrast-enhanced MR imaging with fat suppression can be useful in the characterization of small renal lesions.


Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Sonography, CT, and MR imaging can be successfully used in the detection and characterization of small renal lesions; each of these techniques has unique attributes, and each plays an important role in the evaluation of these lesions [1].

Conventional spin-echo MR imaging does not offer any advantage over CT in the evaluation of small renal masses; the spatial resolution of MR imaging is inferior, and inherent tissue relaxation parameters are not specific or are even misleading [2]. MR imaging with contrast enhancement and fat suppression has proven more sensitive in detecting and characterizing small renal lesions than unenhanced spin-echo sequences [3, 4]. Detection and characterization of small renal lesions has been further improved with breath-hold gradient-echo sequences (fast low-angle shot [FLASH]), before and after an IV bolus injection of a paramagnetic contrast agent (dynamic MR imaging), with enhancement resulting from vascularity of the lesion as a criterion[5,6,7].

We performed this study to evaluate the usefulness of dynamic gadolinium-enhanced MR imaging with fat suppression for the detection and characterization of small renal masses and the assessment of their vascularity.


Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
We retrospectively reviewed the MR images of 35 patients with a single small (<=3.0 cm) renal lesion who had undergone an identical protocol of conventional and dynamic contrast-enhanced fat-suppressed MR imaging. The 26 men and nine women had a mean age of 56.7 ± 15.2 years (range, 38-71 years). The size of the lesions ranged from 1 to 3 cm (mean, 2.44 ± 0.56 cm).

The final diagnoses were renal cell carcinoma in 20 patients (16 clear cell, alveolar, or trabecular carcinomas and four papillary carcinomas) and benign lesions in 15 patients (eight angiomyolipomas and seven complicated cysts). Renal cell carcinomas had been diagnosed by histologic examination after surgery. Angiomyolipomas had been diagnosed on the basis of fat recognition on CT scans and an unchanged sonographic pattern after a 2-year follow-up in seven patients, and by histology after surgery in one equivocal case. All complicated benign cystic lesions had been diagnosed by examination of the aspirate after fine-needle aspiration, and all were confirmed after a 2-year sonographic follow-up that showed no lesion growth.

No patients had venous thrombosis, regional adenopathy, or distant metastases. No cases of oncocytoma, renal metastasis, focal nephritic lesion, or multiple carcinomas were involved in this study.

At time of the MR imaging, all 35 patients had normal overall renal function and symmetric kidneys; the 70 kidneys were free from medical or surgical disease, were of normal size, and were not obstructed.

MR Imaging Protocol
MR imaging was performed with a 1.0-T super-conducting unit (Impact; Siemens, Erlangen, Germany). Scout turboFLASH images (TR/TE, 8.5/4.0 msec; flip angle, 8°; inversion time, 500 msec) were acquired in the coronal plane. A T1-weighted spin-echo sequence (600/15) and a T2-weighted spin-echo sequence (2000/80) in the axial plane were initially performed. For both sequences the matrix size was 192 x 256, the section thickness was 7 mm, and the intersection gap was 1 mm. These sequences were followed by a T1-weighted spoiled gradient-recalled echo sequence with FLASH and the fat-suppression technique (120/6.5), with a flip angle of 70°, a matrix size of 134 x 256, a section thickness of 8 mm, and an intersection gap of 2 mm. This pulse sequence enabled us to acquire four sections in 16 sec during a single breath-hold. The optimal imaging plane was selected with either sagittal or coronal references to unenhanced T1- and T2-weighted spin-echo imaging. When the tumor location could not be identified because of a similarity of the signal intensity of the tumor and renal parenchyma (in four patients with renal cell carcinoma), CT was used as a reference. In two additional patients with renal cell carcinoma, respiratory motion artifacts caused poor image quality on unenhanced T1- and T2-weighted spin-echo sequences, and we also used CT as a reference.

A paramagnetic contrast agent, gadopentetate dimeglumine (Magnevist; Schering, Berlin, Germany), was administered to all patients as a bolus injection (0.1 mmol/kg of body weight injected in 5-8 sec) through a 22-gauge cannula, which was initially placed in the antecubital vein and which was attached through a long connecting tube to a 20-mL syringe to avoid changing the patient's position during the examination. Immediately after the injection of the contrast agent, the connecting tube was flushed with saline. T1-weighted gradient-recalled echo sequences with FLASH and fat suppression were obtained before and repeatedly after the injection of the contrast agent. Considering the start of the bolus injection to be the zero point, imaging was performed at 30, 60, 90, 120, 150, 180, and 210 sec.

MR Image Analysis
Images were separately interpreted by two radiologists and were reviewed by consensus. On the basis of visual inspection, the signal intensity enhancement on dynamic FLASH sequences was graded as either greater than, equal to, or less than that of the normal renal parenchyma, and subsequently the lesions were categorized as hypervascular or hypovascular (avascular).

Quantitative Analysis and Calculations
All MR images were transferred from hard copy to a satellite console (SIENET Magic View 1000; Siemens). The signal intensities of the lesion and of the cortex and medulla were measured in operator-defined circular regions of interest placed manually over the lesion, the cortex, and the medulla of the kidney on unenhanced T1-weighted gradient-recalled echo images and on dynamic gadolinium-enhanced gradient-recalled echo images obtained at each imaging time. The region-of-interest size of the lesion was large enough to encompass a representative area of the mass without being so large as to lead to spurious values because of volume averaging with adjacent normal renal parenchyma. The time of measurements on regions of interest for each patient was approximately 10 min. Background noise was measured in the phase-encoding direction.

We calculated two parameters for each lesion. First, we calculated the percentage of enhancement of signal intensity after the administration of gadolinium with respect to the value on unenhanced images, as follows: percentage of enhancement = (SIpost-SIpre) / SIprex(STDnoisepre/STDnoisepost), where SI stands for signal intensity, STDnoise for standard deviation of noise, and pre and post for unenhanced and contrast-enhanced, respectively. Second, we calculated the contrast-to-noise ratio as being equal to the ratio of the lesion-cortex signal intensity difference to noise. This parameter is a measure of the signal intensity of the lesion relative to that of the cortex—that is, a positive value indicates hyperintensity and a negative value indicates hypointensity with respect to renal cortex.

Statistical Analysis
Analysis of variance and the Newman-Keuls test were used for multiple comparisons of quantitative data. A p value of less than 0.05 was considered statistically significant.


Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Qualitative Analysis
On dynamic gadolinium-enhanced fatsuppressed MR sequences, all renal cell carcinomas could be detected at some time after contrast injection. Ten renal cell carcinomas showed an enhancement that, at visual inspection, after 150 sec became greater than or equal to that of renal cortex and that could be categorized as hypervascular (Fig. 1A,1B,1C,1D); the other 10 showed a constantly lower enhancement and could be categorized as hypovascular (Fig. 2A,2B,2C,2D). All four papillary carcinomas appeared as hypovascular lesions.



View larger version (98K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A. —53-year-old man with hypervascular renal clear cell carcinoma of upper pole of right kidney. Note small simple renal cyst (black arrow). Coronal unenhanced gradient-echo fast low-angle shot (FLASH) T1-weighted MR image with fat suppression (TR/TE, 120/6.5; flip angle, 70°) shows lesion (white arrow).

 


View larger version (99K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B. —53-year-old man with hypervascular renal clear cell carcinoma of upper pole of right kidney. Note small simple renal cyst (black arrow). Gradient-echo FLASH T1-weighted MR images at same level as A show early heterogeneous enhancement of lesion (white arrow) at 30 sec (B), lesion (white arrow) enhancement increasing at 90 sec (C), and lesion (white arrow) enhancement greater than that of renal cortex at 120 sec (D) after gadolinium injection.

 


View larger version (89K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1C. —53-year-old man with hypervascular renal clear cell carcinoma of upper pole of right kidney. Note small simple renal cyst (black arrow). Gradient-echo FLASH T1-weighted MR images at same level as A show early heterogeneous enhancement of lesion (white arrow) at 30 sec (B), lesion (white arrow) enhancement increasing at 90 sec (C), and lesion (white arrow) enhancement greater than that of renal cortex at 120 sec (D) after gadolinium injection.

 


View larger version (83K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1D. —53-year-old man with hypervascular renal clear cell carcinoma of upper pole of right kidney. Note small simple renal cyst (black arrow). Gradient-echo FLASH T1-weighted MR images at same level as A show early heterogeneous enhancement of lesion (white arrow) at 30 sec (B), lesion (white arrow) enhancement increasing at 90 sec (C), and lesion (white arrow) enhancement greater than that of renal cortex at 120 sec (D) after gadolinium injection.

 


View larger version (78K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2A. —65-year-old man with hypovascular renal cell papillary carcinoma of lower pole of left kidney. Coronal unenhanced gradient-echo fast low-angle shot (FLASH) T1-weighted MR image with fat suppression (TR/TE, 120/6.5; flip angle, 70°) shows lesion (arrow).

 


View larger version (68K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2B. —65-year-old man with hypovascular renal cell papillary carcinoma of lower pole of left kidney. Gradient-echo FLASH T1-weighted MR image at same level as A 30 sec after gadolinium injection shows heterogeneous low enhancement of lesion (arrow).

 


View larger version (69K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2C. —65-year-old man with hypovascular renal cell papillary carcinoma of lower pole of left kidney. Gradient-echo FLASH T1-weighted MR images at same level as A 90 (C) and 180 (D) sec after gadolinium injection show that lesion (arrow) remains hypointense with respect to renal cortex.

 


View larger version (70K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2D. —65-year-old man with hypovascular renal cell papillary carcinoma of lower pole of left kidney. Gradient-echo FLASH T1-weighted MR images at same level as A 90 (C) and 180 (D) sec after gadolinium injection show that lesion (arrow) remains hypointense with respect to renal cortex.

 

On dynamic MR sequences, angiomyolipomas, at visual inspection 30 sec after gadolinium injection, appeared hyperintense with respect to the renal cortex in three patients, hypointense in one patients, and isointense in four patients. From 60 to 210 sec, all angiomyolipomas showed a signal intensity enhancement lower than that of renal cortex (Fig. 3A,3B,3C,3D).



View larger version (85K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3A. —51-year-old woman with angiomyolipoma of upper pole of left kidney. Sagittal unenhanced gradient-echo fast low-angle shot (FLASH) T1-weighted MR image with fat suppression (TR/TE, 120/6.5; flip angle, 70°) shows that lesion (arrow) appears hypointense compared with renal parenchyma because of suppression of fat.

 


View larger version (99K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3B. —51-year-old woman with angiomyolipoma of upper pole of left kidney. Gradient-echo FLASH T1-weighted MR image at same level as A 30 sec after gadolinium injection shows early brisk enhancement of lesion (arrow).

 


View larger version (88K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3C. —51-year-old woman with angiomyolipoma of upper pole of left kidney. Gradient-echo FLASH T1-weighted MR images at same level as A 90 (C) and 150 (D) sec after gadolinium injection show that contrast material is washed out and lesion (arrows) appears inhomogeneously hypointense.

 


View larger version (86K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3D. —51-year-old woman with angiomyolipoma of upper pole of left kidney. Gradient-echo FLASH T1-weighted MR images at same level as A 90 (C) and 150 (D) sec after gadolinium injection show that contrast material is washed out and lesion (arrows) appears inhomogeneously hypointense.

 

On dynamic MR sequences, the complicated cysts showed no or minimal enhancement and were classified as avascular lesions (Fig. 4A,4B,4C,4D).



View larger version (107K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4A. —70-year-old woman with complicated cyst of lower third of kidney. Note that another cyst (open arrows) with blood content is present on upper pole; this cyst was not included in quantitative study. Coronal unenhanced gradient-echo fast low-angle shot (FLASH) T1-weighted MR image with fat suppression (TR/TE, 120/6.5; flip angle, 70°) shows inhomogeneous signal intensity of lesion (solid arrow), which is indistinguishable from a solid lesion.

 


View larger version (106K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4B. —70-year-old woman with complicated cyst of lower third of kidney. Note that another cyst (open arrows) with blood content is present on upper pole; this cyst was not included in quantitative study. Gradient-echo FLASH T1-weighted MR images at same level as A 30 (B), 60 (C), and 180 (D) sec after gadolinium injection show no enhancement of lesion (solid arrows).

 


View larger version (104K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4C. —70-year-old woman with complicated cyst of lower third of kidney. Note that another cyst (open arrows) with blood content is present on upper pole; this cyst was not included in quantitative study. Gradient-echo FLASH T1-weighted MR images at same level as A 30 (B), 60 (C), and 180 (D) sec after gadolinium injection show no enhancement of lesion (solid arrows).

 


View larger version (114K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4D. —70-year-old woman with complicated cyst of lower third of kidney. Note that another cyst (open arrows) with blood content is present on upper pole; this cyst was not included in quantitative study. Gradient-echo FLASH T1-weighted MR images at same level as A 30 (B), 60 (C), and 180 (D) sec after gadolinium injection show no enhancement of lesion (solid arrows).

 

Quantitative Analysis
The differentiation between hyper- and hypovascular renal cell carcinomas, which emerged from the visual observations of the qualitative examination, was used for the further analysis of quantitative data.

The time profiles of percentage of enhancement and contrast-to-noise ratio on dynamic FLASH gradient-recalled echo sequences are summarized in Tables 1 and 2, respectively, with statistical significance given. The time profile of percentage of enhancement of hypervascular renal cell carcinomas was similar to that of cortical tissue until 150 sec. In late sequences (180-210 sec) the percentage of enhancement became significantly greater than that of cortex and similar to that of renal medulla. Hypovascular renal cell carcinomas always showed lower values of percentage of enhancement than those of hypervascular renal cell carcinoma, the difference being significant from 60 to 210 sec.


View this table:
[in this window]
[in a new window]

 
TABLE 1 Percentage of Enhancement of Renal Cortex, Medulla, and Lesions at Different Times After IV Injection of Gadolinium

 

View this table:
[in this window]
[in a new window]

 
TABLE 2 Contrast-to-Noise Ratio of Renal Medulla and Lesions at Baseline and at Different Times After IV Injection of Gadolinium

 

Angiomyolipomas had an early peak mean percentage of enhancement at 30 sec, even though they remained hypointense when compared with renal cortex (see contrast-to-noise ratio results). This was because of the shift from a low signal intensity on baseline fat-suppressed sequences to high signal intensity for lesion vascularity as soon as the contrast material was injected. Subsequently, a vascular washout of the gadolinium determined a decline in percentage of enhancement to values similar to that of hypovascular renal cell carcinomas from 90 to 210 sec.

Complicated cysts showed low mean percentage of enhancement values, significantly different from those of all other lesions at all times.

Contrast-to-noise ratio showed that all lesions were hypointense with respect to the renal cortex at baseline. Contrast-to-noise ratio values before the injection of gadolinium were similar for hypervascular and hypovascular renal cell carcinomas and complicated cysts; those of angiomyolipomas were significantly lower because of fat suppression. After the injection of gadolinium, the hypervascular renal cell carcinomas progressively became isointense and, from 150 to 210 sec, hyperintense with respect to renal cortex.

The other lesions remained hypointense, and the gap in signal intensity with the renal cortex increased in the first minute; until 60 sec, hypovascular renal cell carcinomas showed a slight decline in contrast-to-noise ratio, whereas angiomyolipomas and cysts had a sharper decrease, then the respective values for the three lesions remained almost stable until 210 sec.

With the values obtained from measurements of percentage of enhancement and contrast-to-noise ratio, it was possible to draw time curves that, when observed in combination, could shape a typical pattern for each kind of lesion (Figs. 5 and 6).



View larger version (15K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5. —Graph shows time curves of mean percentage of enhancement of signal intensity in renal cortex ({blacktriangleup}), medulla ({diamondsuit}), and different lesions. Note that after 60 sec from contrast injection, hypervascular renal cell carcinoma ({diamond}) enhances more than cortex. Hypovascular renal cell carcinoma ([UNK]) has much lower enhancement. Angiomyolipoma ({square}), after early peak, has enhancement curve similar to that of hypovascular carcinoma. Enhancement of complicated cyst ({circ}) is negligible.

 


View larger version (14K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6. —Graph shows time curves of mean contrast-to-noise ratio of renal medulla ({diamondsuit}) and different lesions. Note that contrast-to-noise ratio of hypervascular renal cell carcinoma ({diamond}) becomes positive from 150 sec after contrast injection; that is, lesion becomes hyperintense with respect to renal cortex. All other lesions remain hypointense, but hypovascular renal cell carcinoma ([UNK]) shows contrast-to-noise ratio curve intermediate between those of hypervascular carcinoma and benign lesions (angiomyolipoma [{square}] and complicated cyst [{circ}]).

 


Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Early detection and surgical excision of renal cell carcinomas are critical for patient survival because it has been shown that small tumors grow in size and metastasize [8,9,10,11,12,13,14]. At present, sonography and CT are the primary techniques for renal tumor imaging at most institutions. Although most lesions are discovered on a sonographic examination, contrast-enhanced CT remains the standard for the diagnosis of small renal cell carcinoma because of its cost, its ready availability, and its image quality. Recently, multiphasic helical CT has increased conspicuity for detection and characterization of small renal masses [15]. Arteriography has a limited role in the evaluation of small lesions, especially when they are hypovascular: minimal enhancement, no abnormal vessels, and no vascularity of the lesion can be shown; if the lesion is centrally located, the surrounding renal vasculature can obscure the blood supply to the tumor [8].

MR imaging of small renal lesions has been limited, not only because of the higher costs and the lower availability of this technique but also because, with conventional spin-echo sequences, small renal cell carcinomas often show a relative regularity or sharpness of margins and appear as homogeneous lesions. On conventional MR imaging, these cases have no specific signal intensity that is diagnostic of renal cell carcinoma. Their signal intensity varies on T1-weighted images from hypo- to hyperintense when compared with the surrounding renal parenchyma, and it increases on T2-weighted images. However, hypointensity on both T1-and T2-weighted images has been described [16,17,18]. Thus, on unenhanced MR imaging, the signal intensity of solid renal tumors can be similar to that of renal parenchyma on both T1- and T2-weighted images, resulting, according to Semelka et al. [6], in only a 63% tumor detection rate when the lesion measures less than 3 cm in diameter.

Indications for the use of MR imaging in the study of small renal lesions include allergy to iodine contrast agents, renal failure, and suboptimal or equivocal CT or sonography studies [4, 5]. The possibility of obtaining sections that are not only transverse but also multiplanar makes MR imaging indicated over conventional CT in patients with a renal mass at either pole of the kidney, for identification of which coronal or sagittal imaging may be useful [16]. Recent developments, including the technique we used in the present study—namely, breath-hold gradient-recalled echo FLASH sequences with fat suppression, before and after the IV administration of gadolinium (dynamic MR imaging)—help to shorten examination times, reduce respiratory motion artifacts, increase the conspicuity of renal lesions, and improve MR imaging in detecting and characterizing renal masses [1, 4, 7, 19,20,21].

In our study we performed a quantitative analysis of signal intensity on MR images. Although transferring MR images to a MagicView workstation is not widely available to practicing radiologists, it is a feasible method for rapidly calculating the percentage of enhancement of renal lesions and their contrast-to-noise ratio with respect to renal cortex.

The degree of vascularity of tissue lesions correlates with the degree of enhancement on contrast-enhanced images [22]. Early enhancement of a renal lesion during the distribution phase of gadolinium reflects blood delivery (capillary phase imaging), depending on tumor vascularity and its blood supply; subsequent enhancement reflects capillary permeability (interstitial imaging) [23]. Becuase gadolinium rapidly equilibrates from the intravascular space into the extracellular space, there is a potential for the signal intensity of the lesion to became isointense relative to the normal parenchyma. Therefore, it is important to perform MR imaging in the first minutes after injection of contrast material [19], as we did with the dynamic sequences in the first 210 sec after contrast injection.

Moreover, cell arrangement with regard to tumor vascularity can correlate with radiologic appearances on gadolinium-enhanced dynamic MR images. In tumors with solid architecture (the most common type of renal cell carcinoma), a large nest of tumor cells is separated by a stroma endowed with prominent sinusoidlike vessels, whereas in tumors with papillary architecture (which were found in four of our 10 patients with hypovascular renal cell carcinoma), neoplastic cells line thin connective tissue stalks with very small vessels [24].

In our patients, on basal, unenhanced gradient-recalled echo sequences, renal cell carcinomas and complicated cysts could be almost indistinguishable because of their similar degree of hypointensity with respect to the renal cortex. Benign, complicated cysts can be difficult to differentiate from malignancies [8]. These cysts have high attenuation on CT scans and can appear as medium- or high-signal-intensity lesions on spin-echo and unenhanced gradient-recalled echo FLASH MR sequences, depending on the age of the blood break-down products or depending on protein concentration. Even though complicated cysts do not enhance, their signal intensity remains higher than that of simple cysts, and they are identified only by comparing unenhanced and contrast-enhanced images [5, 7, 16, 18].

Our results show that, after the administration of gadolinium, hypervascular renal cell carcinoma can be easily differentiated because of the percentage of enhancement and contrast-to-noise ratio curve, which are significantly higher than those of hypovascular renal cell carcinoma and benign lesions (angiomyolipomas and complicated cysts). This can be explained by the fact that all our cases of hypervascular renal cell carcinoma were solid clear cell tumors with alveolar or trabecular architecture and a profuse blood supply.

On the other side, hypovascular renal cell carcinomas, angiomyolipomas, and complicated cysts enhanced significantly less than did cortical and medullary tissue. A simple qualitative or visual observation of the images, at a determinate time after contrast injection, could be confusing by not allowing a correct characterization of the hypointense lesion (Figs. 2A,2B,2C,2D,3A,3B,3C,3D,4A,4B,4C,4D). This is a critical factor, considering the importance of differentiating a malignant (hypovascular renal cell carcinoma) from a benign (angiomyolipoma or cyst) lesion. Quantitative evaluation can be helpful in these cases, providing different signal intensity profiles or time curves for each kind of lesion. In fact, hypovascular renal cell carcinomas, from the first minute after gadolinium injection, showed significantly greater enhancement than complicated cysts. Moreover, hypovascular carcinomas showed mean values of contrast-to-noise-ratio that were always lower than those of hypervascular carcinomas and always greater than those of benign lesions, the latter decreasing and remaining at a significantly lower level.

Renal cell carcinoma can have a cystic aspect, even though such an appearance is rare with small carcinoma. In the patients we studied, all the pathology studies proved renal cell carcinomas were solid and all the cysts had no pathologic proof for true benignity, although we found no malignant cells in the cystic aspiration fluid and, after a 2-year follow-up, no mass enlargement was present. Thus, although complicated cysts show no or minimal enhancement, the possibility exists that they could be difficult to differentiate from minimally enhancing cystic renal cell carcinoma on rare occasions [5].

With our dynamic technique, angiomyolipomas showed a peculiar pattern, with a brisk early (30 sec) percentage of enhancement of signal intensity compared with the basal low intensity caused by fat suppression, and a gradual decrease in intensity (washout) during the remainder of the imaging period. These data agree with the data of other researchers [4]. Of course, the radiologic diagnosis of angiomyolipoma depends on the visualization of fat on unenhanced images (either CT or MR images), and contrast enhancement has a limited diagnostic role.

Our study is limited because it does not include the entire spectrum of renal masses (no cases of oncocytoma, renal metastasis, or focal nephritic lesion). Moreover, the dynamic breath-hold technique we used in this study limits the MR imaging to four slices. For this reason, it is not useful for the screening of renal masses and has a limited value in patients with multiple lesions, some of which can be missed if located on different planes. Rather, this technique can be used for the assessment of single established renal masses.

In conclusion, the potential for lesion characterization is an important benefit of dynamic breath-hold gradient-recalled echo FLASH MR imaging with fat suppression and the IV administration of gadolinium. When a lesion of low signal intensity before the injection of contrast material shows no perceptual enhancement (cystic) after the injection, or a definitive enhancement (solid), no quantitative signal intensity measurements are needed. However, for complicated lesions that show medium or high signal intensity on unenhanced images, quantitative measurements on contrast-enhanced images can be essential.


References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Bosniak MA, Rofsky NM. Problems in the detection and characterization of small renal masses. Radiology 1996; 198:638 -641[Free Full Text]
  2. Choyke PL, Kressel HY, Pollack HM, et al. Focal renal masses: magnetic resonance imaging. Radiology 1984;152:471 -477[Abstract/Free Full Text]
  3. Laniado M, Kommesser W, Deimling M, Felix R. Dynamic MR imaging of renal tumors: fast imaging and Gd-DTPA (abstr). Radiology 1987;161(P):119[Abstract/Free Full Text]
  4. Eilenberg SS, Lee JKT, Brown JJ, Mirowitz SA, Tartar VM. Renal masses: evaluation with gradient-echo Gd-DTPA-enhanced dynamic MR imaging. Radiology 1990;176:333 -338[Abstract/Free Full Text]
  5. Yamashita Y, Miyazaki T, Hatanaka Y, Takahashi M. Dynamic MRI of small renal carcinoma. J Comput Assist Tomogr 1995; 19:759 -765[Medline]
  6. Semelka RC, Hricak H, Stevens SK, Finegold R, Tomei E, Carroll PR. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses. Radiology 1991;178 : 803-809[Abstract/Free Full Text]
  7. Semelka RC, Shoenut JP, Kroeker MA, MacMahon RG, Greenberg HM. Renal lesions: controlled comparison between CT and 1.5-T MR imaging with nonenhanced and gadolinium-enhanced fat-suppressed spin-echo and breath-hold FLASH techniques. Radiology 1992;182 : 425-430[Abstract/Free Full Text]
  8. Bosniak MA. The small (<3.0 cm) renal parenchymal tumor: detection, diagnosis and controversies. Radiology 1991; 179:307 -317[Free Full Text]
  9. Carini M, Selli C, Barbanti G, Lapini A, Turini O, Constantine A. Conservative surgical treatment of renal cell carcinoma: clinical experience and reappraisal of indications. J Urol 1988; 140:725 -731[Medline]
  10. Thompson IM, Peek M. Improvement in survival of patients with renal cell carcinoma: the role of the serendipitously detected tumor. J Urol 1988; 140:487 -490[Medline]
  11. Birnbaum BA, Bosniak MA, Megibow AJ, Lubat E, Gordon RB. Observations of the growth of renal neoplasms. Radiology 1990;176 : 695-701[Abstract/Free Full Text]
  12. Smith SG, Bosniak MA, Megibow AJ, Hulnick DH, Horii SC, Raghavendra BN. Renal cell carcinoma: earlier detection and increase detection. Radiology 1989;170 : 699-703[Abstract/Free Full Text]
  13. Levine E, Huntrakoon M, Wetzel LH. Small renal neoplasms: clinical, pathologic, and imaging features. AJR 1989; 153:69 -73[Abstract/Free Full Text]
  14. Curry NS, Schabel SI, Betsil WLJR. Small renal neoplasms: diagnostic imaging, pathological features, and clinical course. Radiology 1986;158 : 113-117[Abstract/Free Full Text]
  15. Szolar DH, Kammerhuber F, Altziebler S, et al. Multiphasic helical CT of the kidney: increased conspicuity for detection and characterization of small (<3-cm) renal masses. Radiology 1997;202:211 -217[Abstract/Free Full Text]
  16. Sussmann SK, Glickstein MF, Krzymowski GA. Hypointense renal cell carcinoma: MR imaging with pathologic correlation. Radiology 1990;177 : 495-497[Abstract/Free Full Text]
  17. Rofsky NM, Weinreb JC, Bosniak MA, Libes RB, Birnbaum BA. Renal lesion characterization with gadolinium-enhanced MR imaging: efficacy and safety in patients with renal insufficiency. Radiology 1991; 180:85 -89[Abstract/Free Full Text]
  18. Hricak H, Williams RD, Moon KL Jr, et al. Nuclear magnetic resonance imaging of the kidney: renal masses. Radiology 1983;147 : 765-772[Abstract/Free Full Text]
  19. Low RN, Francis IR, Sigeti JS, Foo TKF. Abdominal MR imaging: comparison of T2-weighted fast and conventional spin-echo and contrast-enhanced fast multiplanar spoiled gradient-recalled imaging. Radiology 1993;186 : 803-811[Abstract/Free Full Text]
  20. Lufkin R, Davis WL, Osborn AG. Overview of MR imaging modalities. J Comput Assist Tomogr 1993;17 [suppl 1]:S24 -S29
  21. Venz S, Hierholzer J, Keske U, et al. Imaging tumor extension of renal cell carcinomas with magnetic resonance tomography: improved tumor-tissue contrast with Gd-DTPA-assisted spin-echo sequences and simultaneous fat suppression [in German]. Aktuelle Radiol 1998;8:119 -124[Medline]
  22. Mahfouz A, Hamm B, Taupitz M, Wolf K. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging. Radiology 1993; 186:133 -138[Abstract/Free Full Text]
  23. Brown ED, Semelka RC. Contrast-enhanced magnetic resonance imaging of the abdomen. Magn Reson Q 1994;10 : 97-124[Medline]
  24. Nádasdy T, Bane BL, Silva FG. Adult renal diseases. In: Steinberg SS, ed. Diagnostic surgical pathology, 2nd ed. New York: Raven, 1994;1711 -1718

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Ultrasound MedHome page
L. Fan, D. Lianfang, X. Jinfang, S. Yijin, and W. Ying
Diagnostic Efficacy of Contrast-Enhanced Ultrasonography in Solid Renal Parenchymal Lesions With Maximum Diameters of 5 cm
J. Ultrasound Med., June 1, 2008; 27(6): 875 - 885.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. E. J. Pijl, J. Doornbos, M. N. J. M. Wasser, H. C. van Houwelingen, R. A. E. M. Tollenaar, and J. L. Bloem
Quantitative Analysis of Focal Masses at MR Imaging: A Plea for Standardization
Radiology, June 1, 2004; 231(3): 737 - 744.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
V. B. Ho, S. F. Allen, M. N. Hood, and P. L. Choyke
Renal Masses: Quantitative Assessment of Enhancement with Dynamic MR Imaging
Radiology, September 1, 2002; 224(3): 695 - 700.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scialpi, M.
Right arrow Articles by Rotondo, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scialpi, M.
Right arrow Articles by Rotondo, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS